Wave Life Sciences, Inc. WVE
2.56 USD -0.16 (-5.88%)
Regular-session close
2.61 +0.05 +1.95%
After hours · Nov 20, 5:50 PM ET
2.55 Day range 2.79
2.55 52-week range 21.73
- YTD
- -84.94%
- 1 year
- -62.13%
News
globenewswire.com Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026 INLIGHT Phase 1 data continue to support WVE-007's novel mechanism of action to improve body composition by inducing fat loss without muscle loss, and support a once- or twice-yearly dosing regimenbenzinga.com Citigroup Maintains Buy on Wave Life Sciences, Lowers Price Target to $15 Citigroup analyst Samantha Semenkow maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $19 to $15.
benzinga.com B. Riley Securities Reiterates Buy on Wave Life Sciences, Lowers Price Target to $18 B. Riley Securities analyst Madison El-Saadi reiterates Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $22 to $18.
benzinga.com Canaccord Genuity Maintains Buy on Wave Life Sciences, Raises Price Target to $44 Canaccord Genuity analyst Whitney Ijem maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $42 to $44.
benzinga.com Oppenheimer Maintains Outperform on Wave Life Sciences, Lowers Price Target to $29 Oppenheimer analyst Cheng Li maintains Wave Life Sciences (NASDAQ:WVE) with a Outperform and lowers the price target from $32 to $29.
benzinga.com Wave Life Sciences Anticipates $12M Milestone Payment From GSK In Q4 Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced financial results…
benzinga.com WAVE Life Sciences Q3 EPS $(0.30) Beats $(0.33) Estimate, Sales $13.158M Beat $4.317M Estimate WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 6.25 percent increase over losses of…
